Comparative efficacy and safety of odanacatib, abaloparatide, denosumab, teriparatide, and bisphosphonates for male osteoporosis: a systematic review and network meta-analysis - Quiz - MDSpire

Comparative efficacy and safety of odanacatib, abaloparatide, denosumab, teriparatide, and bisphosphonates for male osteoporosis: a systematic review and network meta-analysis

  • By

  • Chengwu Lu

  • Libao Zhang

  • Changhui Xue

  • Mingxin Liao

  • Jichang Fei

  • Xiaojun Chen

  • Linfeng Wang

  • May 8, 2026

  • 0 min

Share

Original Source(s)

Comparative efficacy and safety of odanacatib, abaloparatide, denosumab, teriparatide, and bisphosphonates for male osteoporosis: a systematic review and network meta-analysis

  • by Chengwu Lu, Libao Zhang, Changhui Xue, Mingxin Liao, Jichang Fei, Xiaojun Chen, Linfeng Wang

  • May 8, 2026

Related Content

Gut microbiota orchestrates bone homeostasis: a multi-pathway network from intestine to skeleton

Lower odds of prevalent vertebral fractures with b/tsDMARD use among rheumatoid arthritis patients in clinical remission: a retrospective observational study

Raman spectroscopic fingerprinting uncovers a multi-scale structural–mechanical–transcriptomic coupling landscape in osteoporosis